Adult-Onset Still's Disease

This is a type of arthritis that starts in adults. It causes fever and other symptoms, unlike regular arthritis. It can affect joints and other parts of the body.

Condition

What people with Adult-Onset Still's Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Adult-Onset Still's Disease?

NameHow it went

About Adult-Onset Still's Disease

What It Is

Adult-onset Still's disease (AOSD) is a rare inflammatory illness that affects the whole body. Its hallmark is a set of symptoms that appear together: high fevers that spike once or twice a day, often to 102.2°F (39°C) or higher; a faint salmon-pink rash, mostly on the chest and thighs, that tends to come and go with the fever; and aching, stiff or swollen joints and muscles. A sore throat, swollen lymph nodes and an enlarged liver or spleen are also common, and blood tests show very high levels of inflammation. AOSD is the adult counterpart of systemic juvenile idiopathic arthritis, a childhood illness first described by the physician George Still, and experts now regard the two as one condition called Still's disease. It usually begins in young adults, though it can start later in life. It matters for three reasons: it is easily mistaken for an infection or other illness, ongoing inflammation can damage joints if it is not controlled, and some people develop serious complications that need fast treatment.

Causes & Risk Factors

The cause of AOSD is unknown. Researchers think it arises when the innate immune system, the body's fast first line of defense, switches on and fails to switch off. The result is a surge of inflammatory signaling proteins, especially interleukin-1 (IL-1), interleukin-6 (IL-6) and interleukin-18 (IL-18), which drive the fever, rash and joint pain. For this reason AOSD is often described as an autoinflammatory disease, which differs from autoimmune diseases such as lupus, where the immune system makes antibodies against the body's own tissues. Infections, particularly viral ones, are suspected triggers in some people, because the illness often begins or flares like a viral infection, with fever and a sore throat. That link has not been proven. Certain gene variants appear to influence who is susceptible, but AOSD is not inherited in a predictable way and usually does not run in families.

How It's Diagnosed

No single test confirms AOSD. The diagnosis rests on recognizing its typical pattern and ruling out other illnesses that look similar, which is why it is often called a diagnosis of exclusion. Infections, lymphoma and other blood cancers, lupus and other autoimmune diseases, and rare inherited fever syndromes can all cause fever, rash and joint pain. The workup therefore often includes blood cultures, tests for specific infections and imaging. Taking this step carefully matters, because steroids and immune-suppressing medicines could do harm if a hidden cancer or infection were the real cause. Blood tests in AOSD typically show a high white blood cell count made up mostly of neutrophils (infection-fighting white cells), raised inflammation markers such as C-reactive protein (CRP) and the erythrocyte sedimentation rate (ESR), and often mildly abnormal liver tests. Ferritin, a protein usually used to measure iron stores, also rises with inflammation, and in AOSD it is frequently far higher than the illness would otherwise explain, which is an important clue. Tests for rheumatoid factor and antinuclear antibodies, markers associated with rheumatoid arthritis and lupus, are usually negative. Some specialist centers also measure IL-18 or calprotectin, which can strongly support the diagnosis but are not widely available. Clinicians often use a checklist called the Yamaguchi criteria, which counts features such as a fever of at least 102.2°F (39°C) lasting a week or more, joint pain lasting two weeks or more, the typical rash and a high white cell count. Visible joint swelling is not required. Arthritis often appears weeks after the fevers begin, and waiting for it can delay treatment.

Treatment Options

Treatment aims to switch off the inflammation quickly, prevent complications and joint damage, and reach remission, meaning no symptoms and normal inflammation tests for at least six months. For a substantial share of people, eventually stopping all medicine is a realistic goal. Medicines that block IL-1 or IL-6 are now the preferred treatment, ideally started as soon as the diagnosis is made. They are biologic drugs, given by injection, that target the signaling proteins driving the disease. Canakinumab (Ilaris), an IL-1 blocker, is approved in the US for active Still's disease, including the adult-onset form. Anakinra (Kineret), a shorter-acting IL-1 blocker, and tocilizumab (Actemra), an IL-6 blocker approved in the US for the childhood form, are also widely used in adults, although for AOSD that use is off label. In practice these medicines can control both the whole-body symptoms and the joint inflammation, and they greatly reduce the need for steroids. Their main trade-off is a higher risk of infections, somewhat more so with IL-6 blockers, so recommended vaccines are usually brought up to date before starting. Corticosteroids such as prednisone act quickly and are often used at high doses at the start, especially when symptoms are severe. Because long-term use often causes significant side effects, the plan is to lower the dose within weeks, reach a low dose by about three months and stop by about six months, adding or changing other medicines if that is not possible. NSAIDs (nonsteroidal anti-inflammatory drugs) such as ibuprofen or naproxen can ease fever and aches while tests are underway, but there is no good evidence that they control the disease itself. Methotrexate, an older immune-modulating medicine, may help reduce steroid needs or treat persistent arthritis, mainly where biologic drugs are not available. People whose disease does not respond to these options are usually managed together with a specialist center, where newer or experimental treatments may be considered.

What to Expect

The course of AOSD varies widely and is hard to predict at the start. Some people have a single episode lasting weeks to months, usually less than a year, that then settles for good. Others have repeated flares separated by symptom-free stretches of weeks to years, and later flares are often milder and shorter than the first. A third group has chronic disease with persistent symptoms, in which ongoing joint inflammation often becomes the main problem and can damage joints such as the knees, wrists, ankles and hips if it is not well controlled. Most people do not develop life-threatening complications. Starting an IL-1 or IL-6 blocker early may lower the chance of the chronic pattern, and many people now reach remission without steroids. Follow-up involves regular visits and blood tests, including CRP and ferritin, to confirm that inflammation stays switched off and to check for medicine side effects. Once remission has held for several months without steroids, biologic treatment is usually tapered gradually, by spacing out injections, rather than stopped suddenly, since an abrupt stop can bring on a more severe flare. Flares can return even after long quiet periods, so learning to recognize your own early signs, such as returning evening fevers or rash, is part of living with the condition. When the disease is chronic and joints are involved, it can limit work and daily activities, so practical support at work and at home can matter as much as medication.

When to Seek Help

See a doctor soon, and ask about referral to a rheumatologist, if you have repeated high fevers with a rash and joint or muscle pain that no infection explains, especially if they last more than a week. If you have AOSD, contact your care team right away about returning fevers or rash, any new or unexpected symptom, or signs of infection while taking an IL-1 or IL-6 blocker, since these medicines can make fevers less obvious. The most serious complication, macrophage activation syndrome (MAS), is an uncontrolled immune overreaction that affects roughly 15 to 20 percent of people with Still's disease. It can occur at onset, during treatment or even in remission, and it is detected mainly through blood tests, so a fever that will not settle or feeling much sicker needs prompt assessment. Also mention a persistent cough or gradually increasing breathlessness, which can signal lung involvement. Seek emergency care for severe difficulty breathing or chest pain, which can mean inflammation around the heart or in the lungs.

Questions to Ask Your Doctor

  1. 1.Which other causes of my fevers and rash have been ruled out, and are any tests still needed?
  2. 2.Would an IL-1 or IL-6 blocker be the right first treatment for me, and how quickly should it work?
  3. 3.How will we lower and stop steroids, and what should I watch for while we do?
  4. 4.Which symptoms or blood test changes would make you worry about macrophage activation syndrome?
  5. 5.If I reach remission, how and when could we try reducing or stopping my medicines?

Last reviewed • Oct 2026

Educational content, not medical advice.